Search for: "PFIZER INC"
Results 1381 - 1400
of 1,505
Sorted by Relevance
|
Sort by Date
15 Sep 2011, 11:58 am
Well, back in 2009 I wrote about how that turned out by quoting a WSJ story: Now, four years after that decision gave Susette Kelo’s land to private developers for a project including a hotel and offices intended to enhance Pfizer Inc. [read post]
23 Feb 2011, 9:20 am
Aventis Pasteur, Inc., 2011 Pa. [read post]
29 Nov 2011, 10:49 am
Pfizer, Inc. [read post]
17 Jan 2009, 6:37 am
• Pfizer eliminated 800 research jobs and 2,400 sales jobs this week. [read post]
31 Aug 2023, 11:01 am
As for vendors, naturally the top vendors are almost all giants, such as Pfizer, Lockheed Martin, and Raytheon. [read post]
4 Sep 2012, 1:21 pm
Pfizer, Inc., 2012 U.S. [read post]
27 Mar 2009, 8:00 am
; no skulduggery involved in pharma enquiry submission switch says EPO (IPKat) (IAM) India: Public sector IP and socially responsible licensing (Spicy IP) India: Pharma lobby wants a probe into delayed orders (Spicy IP) UK: Euro costs in UK litigation: Actavis UK Ltd v Novartis AG (PatLit) US: Two biosimilars bills introduced in the House: HR 1427, the Promoting Innovation and Access to Life Saving Medicine Act; and H.R. 1548, the Pathway to BioSimilars Act (California Biotech Law Blog) (Managing… [read post]
27 Jan 2014, 9:45 am
” She advocates a carful application of the factors enunciated Pfizer, Inc. [read post]
6 Apr 2011, 12:18 am
427/09 Generics (UK) Ltd v Synaptech Inc (The SPC Blog) Simcor (Niacin, Simvastatin) – US: Abbott files patent infringement complaint against Watson following Para IV certification filing (Patent Docs) Thalomid (Thalidomide) – US: Decision in Lannett Thalomid bioequivalence study sample antitrust lawsuit could reignite debate on generic drug availability and REMS restrictions (FDA Law Blog) Yasmin (Drospirenone, Ethinylestradiol) – UK: Bayer Yasmin patents survive patent… [read post]
26 Apr 2010, 7:05 pm
Pfizer, Inc., 244 Conn. 598, 619 (1998) (McDonald, J., concurring) (Fourth amendment law recognizes that the collective knowledge of the police determines probable cause. [read post]
15 Jul 2014, 5:27 am
Jay Martin, Chief Compliance Officer (CCO) at BakerHughes Inc. suggests an approach that reviews key risk factors to move forward. [read post]
25 Jul 2007, 12:42 pm
Patent and Trademark Office (USPTO) to grant a request for reexamination of four key HIV/AIDS drug patents held by Gilead Sciences Inc. [read post]
29 May 2011, 12:01 pm
Pfizer, Inc., 233 P.3d 1066 (Cal. 2010), make clear that section 17204 only requires that a party allege an injury in fact and that the injury was caused by the defendant. [read post]
24 May 2010, 5:25 am
Pfizer, Inc., 2010 U.S. [read post]
7 Apr 2010, 4:30 am
Reddy's Laboratories, Ltd. et al (Docket Report) Retin-A Micro (Tretinoin) – US: District Court E D Texas: Promote Innovation files false marking complaint against Ortho-McNeil based on marking of Retin-A Micro product (Patent Docs) Seasonique (Levonorgestrel, Ethinyl estradiol) – US: Teva receives favourable court decision regarding Seasonique (SmartBrief) (The IP Factor) T2007 (Diphenyl barbituric acid) – US: Taro receives patent for new drug T2007 (The IP Factor)… [read post]
16 Nov 2010, 5:45 am
The court relied heavily on Pfizer, Inc. v. [read post]
3 Mar 2010, 5:05 am
(IP Think Tank) US: Reverse payments in generic drug settlements (Part II - Patent Docs) (Part III - Patent Docs) (Part IV - Patent Docs) US: Inability of patent examiner and Board to correctly read prior art reference necessitates intervention by Federal Circuit: In re Chapman (Holman's Biotech IP Blog) (Patent Docs) US: Patent infringement suit between NexMed and Beta Technologies stayed following determination that plaintiff NexMed may not own one of the patents-in-suit related to method of… [read post]
9 Aug 2011, 4:30 am
Pfizer, 232 F.R.D. 360 (C.D. [read post]
19 Aug 2008, 10:35 pm
Vioxx came on the market in June 1999, after rival Pfizer Inc.'s Celebrex. [read post]
2 Mar 2022, 10:39 am
For example, Holmes’ added the Pfizer logo to company reports, which led large investors, like Walgreens, to believe that the blood tests had been validated by the pharmaceutical giant. [read post]
